Literature DB >> 9121165

In vitro response of Blastocystis hominis against traditional Chinese medicine.

L Q Yang1, M Singh, E H Yap, G C Ng, H X Xu, K Y Sim.   

Abstract

This is the first inn vitro study on the activity of 20 kinds of crude extracts of traditional Chinese medicine (TCM) on the intestinal parasite, Blastocystis hominis using the criteria of living cell count (LCC) and living cell rate (LCR). LCC and LCR were applied as observation indicators, the former as a fixed-quantity and the latter as a fixed-quality method. LCR calculated percentage rate of living cells using eosin-brilliant cresyl blue staining which could differentiate between living cells and dying or dead cells. There were five extracts with no inhibitory activity, thirteen with moderate inhibition and two with high inhibition. The crude extracts of Coptis chinensis (CC) and Brucea javanica (BJ) were found to be most active against B. hominis. The active concentration of CC was 100 micrograms/ml. The active concentration of BJ was 500 micrograms/ml. The active concentration of metronidazole (MD) was 10 micrograms/ml and this was taken as an active standard drug for B. hominis.

Entities:  

Mesh:

Year:  1996        PMID: 9121165     DOI: 10.1016/s0378-8741(96)01471-7

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  Antiprotozoal potential of Salvadora persica against three virulent subtypes of Blastocystis sp.

Authors:  Mohammed A El-Bali; Abdulhafid Abdulhakim; Raafat T Mohamed; Mohamed A El-Malky; Rowaida A Bakri; Saeed A Al-Harthi
Journal:  J Parasit Dis       Date:  2020-07-27

2.  Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract.

Authors:  Meifen Zhu; Ning Wang; Sai-Wah Tsao; Man-Fung Yuen; Yigang Feng; Thomas S K Wan; Kwan Man; Yibin Feng
Journal:  Exp Ther Med       Date:  2010-11-19       Impact factor: 2.447

3.  In vitro Effect of Silver Nanoparticles on Blastocystis hominis.

Authors:  Mohamed Saad Younis; Eman Abd El Rahman Abououf; Ali El Saeed Ali; Sara Mohamed Abd Elhady; Rita Maher Wassef
Journal:  Int J Nanomedicine       Date:  2020-10-22

4.  Differences in the in vitro susceptibility of mono-eukaryotic cultures of Histomonas meleagridis, Tetratrichomonas gallinarum and Blastocystis sp. to natural organic compounds.

Authors:  Elvira Grabensteiner; Najma Arshad; Michael Hess
Journal:  Parasitol Res       Date:  2007-02-07       Impact factor: 2.289

5.  Antiprotozoal activities determined in vitro and in vivo of certain plant extracts against Histomonas meleagridis, Tetratrichomonas gallinarum and Blastocystis sp.

Authors:  Elvira Grabensteiner; Dieter Liebhart; Najma Arshad; Michael Hess
Journal:  Parasitol Res       Date:  2008-08-28       Impact factor: 2.289

6.  Inhibitory effect of Ferula asafoetida L. (Umbelliferae) on Blastocystis sp. subtype 3 growth in vitro.

Authors:  Hala K El Deeb; Faisal M Al Khadrawy; Ayman K Abd El-Hameid
Journal:  Parasitol Res       Date:  2012-05-15       Impact factor: 2.289

7.  Anti-blastocystosis activity of antioxidant coated ZIF-8 combined with mesoporous silicas MCM-41 and KIT-6.

Authors:  B Rabindran Jermy; Reem Y Al-Jindan; Vijaya Ravinayagam; Ayman A El-Badry
Journal:  Sci Rep       Date:  2022-04-17       Impact factor: 4.996

8.  Atorvastatin: In-Vivo Synergy with Metronidazole as Anti-Blastocystis Therapy.

Authors:  Maha M A Basyoni; Shawky A Fouad; Marwa F Amer; Ahmed Fathy Amer; Dalia Ibrahim Ismail
Journal:  Korean J Parasitol       Date:  2018-04-30       Impact factor: 1.341

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.